Multiple paths towards repair in multiple sclerosis

Trends in Neurosciences

Volumn 26, Issue 2, 2003, Pages 59-61

  Colman, David ^a   Lubetzki, Catherine ^b   Reingold, Stephen ^c  

^a MCGILL UNIVERSITY   (Canada)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c National Multiple Sclerosis Society   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN ATROPHY; BRAIN INJURY; CELL LOSS; CONVALESCENCE; DIFFUSION TENSOR IMAGING; HISTOPATHOLOGY; HUMAN; MULTIPLE SCLEROSIS; NERVE FIBER GROWTH; NERVE FIBER REGENERATION; NERVOUS SYSTEM INFLAMMATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REMYELINIZATION; SHORT SURVEY; SPECTROSCOPY;

HUMANS; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVE GROWTH FACTOR; NERVE REGENERATION; NEURONS; TISSUE TRANSPLANTATION;

EID: 0037302656     PISSN: 01662236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-2236(02)00015-2     Document Type: Short Survey

References (18)

1. Prineas J.W., et al. Graham D.I., Lantos P.L. Greenfield's Neuropathology. 7th edn:2002;471-550 Arnold.
2. Miller D.H., et al. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain. 125:2002;1676-1695.
3. Kalkers N.F., et al. Longitudinal brain volume measurement in multiple sclerosis: rate of brain atrophy is independent of disease subtype. Arch. Neurol. 59:2002;1572-1576.
4. Cai D., et al. Arginase I and polyamines act downstream from cyclic AMP in overcoming inhibition of axonal growth MAG and myelin in vitro. Neuron. 35:2002;711-719.
5. Strittmatter S.M. Modulation of axonal regeneration in neurodegenerative disease: focus on Nogo. J. Mol. Neurosci. 19:2002;117-121.
6. Doherty P., et al. CAMs and axonal growth: a critical evaluation of the role of calcium and the MAPK cascade. Mol. Cell. Neurosci. 16:2000;283-295.
7. Sur M., Leamey C.A. Development and plasticity of cortical areas and networks. Nat. Rev. Neurosci. 2:2001;251-262.
8. Charles P., et al. Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain. 125:2002;1972-1979.
9. Mitsunaga Y., et al. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J. 16:2002;1325-1327.
10. Windrem M.S., et al. Progenitor cells derived from the adult human subcortical white matter disperse and differentiate as oligodendrocytes within demyelinated lesions of the rat brain. J. Neurosci. Res. 69:2002;966-975.
11. Bonilla S., et al. Hematopoietic progenitor cells from adult bone marrow differentiate into oligodendrocyte progenitors in the neonatal mouse. Eur. J. Neurosci. 15:2002;575-582.
12. Toma J.G. Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat. Cell Biol. 3:2001;778-784.
13. Lakatos A., et al. Olfactory ensheathing cells and Schwann cells differ in their in vitro interactions with astrocytes. Glia. 32:2000;214-225.
14. Wu Y.Y., et al. Isolation of a glial-restricted tripotential cell line from embryonic spinal cord cultures. Glia. 38:2002;65-79.
15. Spassky N., et al. Directional guidance of oligodendroglial migration by class 2 semaphorins and netrin-1. J. Neurosci. 22:2002;5992-6004.
16. Blakemore W.F., et al. Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS. Glia. 38:2002;155-168.
17. Zhang S.-C., Duncan I.D. Dunnett S.B., Bjorklund A. Functional Neural Transplantation. 1999;515-533 Elsevier.
18. Baron-Van Evercooren A., et al. Schwann cell transplantation and myelin repair of the CNS. Mult. Scler. 3:1997;157-161.